Upcoming PDUFA dates and FDA decisions This Biotech Investment Group will discuss upcoming PDUFA dates and FDA decisions and their impact on biotech stocks. User(s) active in this forum: 0
Biotech companies running out of cash This Group will discuss biotech companies that are running out of cash. We define this as 1 or less years of cash based the biotech company's cash burn. This forum will discuss the likelihood of biotech financing, the effects of dilution and impact on biotech stock price. User(s) active in this forum: 0
Well financed biotech compaines and well backed biotech stocks Cash is king in the biotechnology sector. This forum will discuss the biotech companies that have more than $100 million in cash but no products on the market. These are biotech companies that have the financial resources to develop a drug or product and now need to execute and create value for the stock holder. User(s) active in this forum: 0
Novel biotech drug development targets, clinical trials, approaches and technologies This biotech forum will discuss the latest and greatest drug targets, therapeutic antibodies, small molecules, nucleic acid inhibitors (RNAi, antisense dna), methodologies and approaches to biotech and pharmaceutical drug development. User(s) active in this forum: 0
Biotech and phamaceutical company deals, partnerships and alliances This forum will discuss current biotech and pharmaceutical company deals, partnerships and alliances, with a focus on deal terms, deal structure and strategic advantage. The group will further assess how a specific partnership may impact stock price and other companies in the biotechnology sector. User(s) active in this forum: 0
